Medtronic PLC (Germany) Performance
| 2M6 Stock | EUR 82.19 0.46 0.56% |
Medtronic PLC has a performance score of 4 on a scale of 0 to 100. The company secures a Beta (Market Risk) of -0.12, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Medtronic PLC are expected to decrease at a much lower rate. During the bear market, Medtronic PLC is likely to outperform the market. Medtronic PLC right now secures a risk of 1.1%. Please verify Medtronic PLC mean deviation, downside deviation, standard deviation, as well as the relationship between the semi deviation and coefficient of variation , to decide if Medtronic PLC will be following its current price movements.
Risk-Adjusted Performance
4 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Medtronic PLC are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Medtronic PLC is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 3.6 B | |
| Total Cashflows From Investing Activities | -1.7 B |
Medtronic |
Medtronic PLC Relative Risk vs. Return Landscape
If you would invest 7,908 in Medtronic PLC on September 3, 2024 and sell it today you would earn a total of 311.00 from holding Medtronic PLC or generate 3.93% return on investment over 90 days. Medtronic PLC is currently producing 0.0654% returns and takes up 1.1039% volatility of returns over 90 trading days. Put another way, 9% of traded stocks are less volatile than Medtronic, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Medtronic PLC Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medtronic PLC's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Medtronic PLC, and traders can use it to determine the average amount a Medtronic PLC's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0592
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | 2M6 | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.1 actual daily | 9 91% of assets are more volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Medtronic PLC is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medtronic PLC by adding it to a well-diversified portfolio.
Medtronic PLC Fundamentals Growth
Medtronic Stock prices reflect investors' perceptions of the future prospects and financial health of Medtronic PLC, and Medtronic PLC fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medtronic Stock performance.
| Return On Equity | 0.0784 | |||
| Return On Asset | 0.0449 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.22 % | |||
| Current Valuation | 113.84 B | |||
| Shares Outstanding | 1.33 B | |||
| Price To Earning | 26.98 X | |||
| Price To Book | 1.99 X | |||
| Price To Sales | 3.15 X | |||
| Revenue | 31.69 B | |||
| EBITDA | 8.78 B | |||
| Cash And Equivalents | 9.85 B | |||
| Cash Per Share | 7.35 X | |||
| Total Debt | 20.37 B | |||
| Debt To Equity | 50.40 % | |||
| Book Value Per Share | 38.67 X | |||
| Cash Flow From Operations | 7.35 B | |||
| Earnings Per Share | 2.89 X | |||
| Total Asset | 90.98 B | |||
About Medtronic PLC Performance
By analyzing Medtronic PLC's fundamental ratios, stakeholders can gain valuable insights into Medtronic PLC's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Medtronic PLC has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Medtronic PLC has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company was founded in 1949 and is headquartered in Dublin, Ireland. MEDTRONIC PLC operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 101013 people.Things to note about Medtronic PLC performance evaluation
Checking the ongoing alerts about Medtronic PLC for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Medtronic PLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 85.0% of the company shares are owned by institutions such as pension funds |
- Analyzing Medtronic PLC's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medtronic PLC's stock is overvalued or undervalued compared to its peers.
- Examining Medtronic PLC's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medtronic PLC's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medtronic PLC's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Medtronic PLC's stock. These opinions can provide insight into Medtronic PLC's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Medtronic Stock analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |